According to Innoviva's latest financial reports the company's current earnings (TTM) are $0.19 B. In 2022 the company made an earning of $0.28 B a decrease over its 2021 earnings that were of $0.44 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $0.19 B | -32.36% |
2022 | $0.28 B | -35.56% |
2021 | $0.44 B | 25.7% |
2020 | $0.35 B | 52.11% |
2019 | $0.23 B | 10.77% |
2018 | $0.21 B | 56.59% |
2017 | $0.13 B | 125.53% |
2016 | $59.53 M | -417.36% |
2015 | -$18.76 M | -74.49% |
2014 | -$73.53 M | -25.19% |
2013 | -$98.29 M | 430.06% |
2012 | -$18.55 M | -83.92% |
2011 | -$0.12 B | 39.82% |
2010 | -$82.5 M | 2.84% |
2009 | -$80.22 M | -8.62% |
2008 | -$87.79 M | -47.92% |
2007 | -$0.17 B | -5.92% |
2006 | -$0.18 B | 19.8% |
2005 | -$0.15 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | -194.96% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$18.95 M | -109.76% | ๐บ๐ธ USA |